Ingredients

FDA Perspectives: Common Deficiencies in Abbreviated New Drug Applications: Part 1: Drug Substance

January 02, 2010

Team leaders in FDA's Office of Generic Drugs provide an overview.

Refocusing Our Resources

January 02, 2010

From healthcare to corruption to life expectancy, here's what we can learn from the past decade.

Personnel Problems

January 02, 2010

Directors and staff miss the mark when it comes to following procedures.

Week of Dec. 28, 2009: Company and People Notes: Ambit Biosciences And Astellas Pharma Form Agreement; Merck Discontinues Development of MK-1903; and More.

December 31, 2009

ePT--the Electronic Newsletter of Pharmaceutical Technology

BioNanomatrix (Philadelphia) names Edward Erickson president and CEO; and More.

Week of Dec. 21, 2009: Company and People Notes: Merck & Co.Acquires Avecia Biologics; Ambrilia Biopharma Closes Manufacturing Facility; And More.

December 23, 2009

ePT--the Electronic Newsletter of Pharmaceutical Technology

Merck & Co. Acquires Avecia Biologics; Ambrilia Biopharma Closes Manufacturing Facility; And More.

Eli Lilly Outlines Growth Strategy

December 17, 2009

ePT--the Electronic Newsletter of Pharmaceutical Technology

Eli Lilly outlined its growth strategy at its annual meeting with the investment community last week.

Week of Dec. 14, 2009: Company Notes: Sanofi Pasteur recalls H1N1 vaccine; Patheon consolidates Puerto Rico operations.

December 17, 2009

ePT--the Electronic Newsletter of Pharmaceutical Technology

Also, Abbott to acquire Starlims Technologies; GSK Biologicals to form alliance with Intercell.

Week of Dec. 7, 2009: Company and People Notes: PhRMA adds biopharm members; Dow spins off expression technology; and more.

December 10, 2009

ePT--the Electronic Newsletter of Pharmaceutical Technology

Company and People Notes: Also, Pfizer and Protalix enter agreement; Watson acquires Arrow Group; and more.

Week of Nov. 30, 2009: Company and People Notes: BASF introduces new tablet-coating system; Catalent achieves ISO 15378 certification; and More.

December 03, 2009

ePT--the Electronic Newsletter of Pharmaceutical Technology

Also, Merck & Co. extends collaboration with Idera Pharmaceuticals; Pfizer establishes R&D center in China; more...

Moisture-Activated Dry Granulation Part II: The Effects of Formulation Ingredients and Manufacturing-Process Variables on Granulation Quality Attributes

December 02, 2009

In this article, the authors evaluated the effects of the granulating binder level, binder type, water amount, and water-droplet size on the MADG process.